IZOZF
PINK Izotropic Corp.$0.1325 ↓ -0.0009 (-0.67%) Trading Down from the previous close of $0.1334, $0.0229 below the day’s high of $0.1554
- YTD change
- -34.73%
- vs 20-day SMA
- -13.60%
- vs 200-day SMA
- -28.33%
Price ranges
Price & Performance
-0.02 (-13.94%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 89.9% away from all-time highs of $1.3100
- IZOZF is down 35% since the beginning of the year
- IZOZF is down 52% over the past 12 months
- IZOZF is down 23% over the past 1 month
- 0% of all IZOZF investors are betting against IZOZF
IZOZF reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -52.1%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0052
- Last 5 days
- -16.82%
- vs 8-day SMA
- -10.07%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Izotropic Corp. is engaged in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. Its initial plan was to complete the engineering of the first imaging device and seek approval in the USA as a diagnostic device for detecting breast cancers. The company was founded by John M. Boone and Robert Louis Thast on May 19, 2016, and is headquartered in Surrey, Canada.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.